Home
Blog
Features
Sign Up
Try the Demo today!
Home
Market
Reports
Search
Alerts
Ticker
Company Name
Insider Name
Insider Trading Guide
About
Contact Us
Login
Goldberg Mark Alan
Insider Overview
Current Sentiment
Insider Transactions
Email this page »
View:
Company
Atyr Pharma Inc
Audentes Therapeutics, Inc.
Blueprint Medicines Corp
Glycomimetics Inc
Idera Pharmaceuticals, Inc.
Immunogen Inc.
Trimeris Inc.
Immunogen Inc.
Director
Avg. Two Year Performance
30%
Avg. Purchase Return
14%
Compound
No Sale Track Record
Holdings: 0 shares
Last Three Months: 23-Aug-24 -- 22-Nov-24
0
Net Amount
Buy:
0
--
Sell:
0
--
Sentiment
Company Sentiment
Biotechnology
Drugs
Two Year Chart
23-Nov-22 -- 22-Nov-24
Price ($)
Sentiment
Company Sentiment
Most Recent Insider Transactions
